Research Focus

Medicine; Assistant Attending

Recent additions – View all

1. Results of a phase Ib study investigating durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer

   Journal Article

   Landry, C. A.; Blanter, J.; Ru, M.; Fasano, J.; Klein, P.; Shao, T.; Bhardwaj, A.; Tiersten, A.
   Oncology (2024)

   Fulltext@MSK | Save